The loss of neurofibromin function, a protein known to downregulate the Ras pathway, can activate the GTPase activity of Ras/MAPK and PI3K/AKT/mTOR pathways [36], potentially explaining its role as a driver in MTC. This evidence concerns the gene AKT1 and medullary thyroid gland carcinoma.